Market Research Logo

Hepatitis B - Pipeline Review, H1 2015

Hepatitis B - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Hepatitis B - Pipeline Review, H1 2015’, provides an overview of the Hepatitis B’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Hepatitis B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hepatitis B and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Hepatitis B
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Hepatitis B and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Hepatitis B products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Hepatitis B pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Hepatitis B
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Hepatitis B pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Hepatitis B Overview
Therapeutics Development
Hepatitis B - Therapeutics under Development by Companies
Hepatitis B - Therapeutics under Investigation by Universities/Institutes
Hepatitis B - Pipeline Products Glance
Hepatitis B - Products under Development by Companies
Hepatitis B - Products under Investigation by Universities/Institutes
Hepatitis B - Companies Involved in Therapeutics Development
Hepatitis B - Therapeutics Assessment
Drug Profiles
Hepatitis B - Recent Pipeline Updates
Hepatitis B - Dormant Projects
Hepatitis B - Discontinued Products
Hepatitis B - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Hepatitis B, H1 2015
Number of Products under Development for Hepatitis B - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Development by Companies, H1 2015 (Contd..1)
Number of Products under Development by Companies, H1 2015 (Contd..2)
Number of Products under Development by Companies, H1 2015 (Contd..3)
Number of Products under Development by Companies, H1 2015 (Contd..4)
Number of Products under Development by Companies, H1 2015 (Contd..5)
Number of Products under Development by Companies, H1 2015 (Contd..6)
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Development by Companies, H1 2015 (Contd..2)
Products under Development by Companies, H1 2015 (Contd..3)
Products under Development by Companies, H1 2015 (Contd..4)
Products under Development by Companies, H1 2015 (Contd..5)
Products under Development by Companies, H1 2015 (Contd..6)
Products under Development by Companies, H1 2015 (Contd..7)
Products under Investigation by Universities/Institutes, H1 2015
Hepatitis B - Pipeline by Abivax S.A., H1 2015
Hepatitis B - Pipeline by AiCuris GmbH & Co. KG, H1 2015
Hepatitis B - Pipeline by Akshaya Bio Inc., H1 2015
Hepatitis B - Pipeline by Alnylam Pharmaceuticals, Inc., H1 2015
Hepatitis B - Pipeline by AlphaMab Co., Ltd, H1 2015
Hepatitis B - Pipeline by AltraVax Inc., H1 2015
Hepatitis B - Pipeline by Amarna Therapeutics B.V., H1 2015
Hepatitis B - Pipeline by Arrowhead Research Corporation, H1 2015
Hepatitis B - Pipeline by Assembly Biosciences, Inc., H1 2015
Hepatitis B - Pipeline by Beijing Minhai Biotechnology Co., Ltd, H1 2015
Hepatitis B - Pipeline by Benitec Biopharma Limited, H1 2015
Hepatitis B - Pipeline by Big DNA Ltd., H1 2015
Hepatitis B - Pipeline by BioDiem Ltd, H1 2015
Hepatitis B - Pipeline by Biogenomics Limited, H1 2015
Hepatitis B - Pipeline by Biological E. Limited, H1 2015
Hepatitis B - Pipeline by BioStar Pharmaceuticals, Inc., H1 2015
Hepatitis B - Pipeline by Bolder Biotechnology, Inc., H1 2015
Hepatitis B - Pipeline by Bukwang Pharm.Co., Ltd., H1 2015
Hepatitis B - Pipeline by Celltrion, Inc., H1 2015
Hepatitis B - Pipeline by Chimerix, Inc., H1 2015
Hepatitis B - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H1 2015
Hepatitis B - Pipeline by ChronTech Pharma AB, H1 2015
Hepatitis B - Pipeline by Cytos Biotechnology AG, H1 2015
Hepatitis B - Pipeline by Dynavax Technologies Corporation, H1 2015
Hepatitis B - Pipeline by Enyo Pharma S.A.S., H1 2015
Hepatitis B - Pipeline by F. Hoffmann-La Roche Ltd., H1 2015
Hepatitis B - Pipeline by GeneCure LLC, H1 2015
Hepatitis B - Pipeline by Genexine, Inc., H1 2015
Hepatitis B - Pipeline by Gilead Sciences, Inc., H1 2015
Hepatitis B - Pipeline by GlaxoSmithKline Plc, H1 2015
Hepatitis B - Pipeline by Green Cross Corporation, H1 2015
Hepatitis B - Pipeline by HEC Pharm Co., Ltd., H1 2015
Hepatitis B - Pipeline by Humabs BioMed SA, H1 2015
Hepatitis B - Pipeline by Ildong Pharmaceutical Co., Ltd., H1 2015
Hepatitis B - Pipeline by Immunotope, Inc., H1 2015
Hepatitis B - Pipeline by Immunovaccine, Inc., H1 2015
Hepatitis B - Pipeline by Inbiopro Solutions Pvt. Ltd., H1 2015
Hepatitis B - Pipeline by Indian Immunologicals Limited, H1 2015
Hepatitis B - Pipeline by iQur Limited, H1 2015
Hepatitis B - Pipeline by ISA Pharmaceuticals B.V., H1 2015
Hepatitis B - Pipeline by Isis Pharmaceuticals, Inc., H1 2015
Hepatitis B - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H1 2015
Hepatitis B - Pipeline by Johnson & Johnson, H1 2015
Hepatitis B - Pipeline by Leukocare AG, H1 2015
Hepatitis B - Pipeline by LG Life Sciences, Ltd., H1 2015
Hepatitis B - Pipeline by Ligand Pharmaceuticals, Inc., H1 2015
Hepatitis B - Pipeline by Mologen AG, H1 2015
Hepatitis B - Pipeline by Mucosis B.V., H1 2015
Hepatitis B - Pipeline by MultiCell Technologies, Inc., H1 2015
Hepatitis B - Pipeline by Novira Therapeutics, Inc., H1 2015
Hepatitis B - Pipeline by Panacea Biotec Limited, H1 2015
Hepatitis B - Pipeline by Pfenex Inc., H1 2015
Hepatitis B - Pipeline by PharmaEssentia Corporation, H1 2015
Hepatitis B - Pipeline by Redx Pharma Plc, H1 2015
Hepatitis B - Pipeline by REPLICor Inc., H1 2015
Hepatitis B - Pipeline by Romark Laboratories, L.C., H1 2015
Hepatitis B - Pipeline by Sanofi Pasteur SA, H1 2015
Hepatitis B - Pipeline by SEEK Group, H1 2015
Hepatitis B - Pipeline by Sinovac Biotech Ltd., H1 2015
Hepatitis B - Pipeline by SK Chemicals Co., Ltd., H1 2015
Hepatitis B - Pipeline by Spring Bank Pharmaceuticals, Inc., H1 2015
Hepatitis B - Pipeline by TCM Biotech International Corp, H1 2015
Hepatitis B - Pipeline by Tekmira Pharmaceuticals Corp., H1 2015
Hepatitis B - Pipeline by TetraLogic Pharmaceuticals, H1 2015
Hepatitis B - Pipeline by Theravectys S.A., H1 2015
Hepatitis B - Pipeline by Transgene SA, H1 2015
Hepatitis B - Pipeline by Vaxine Pty Ltd, H1 2015
Hepatitis B - Pipeline by Viriom Ltd., H1 2015
Hepatitis B - Pipeline by VLP Biotech, Inc., H1 2015
Hepatitis B - Pipeline by WaterStone Pharmaceuticals, Inc., H1 2015
Hepatitis B - Pipeline by Zydus Cadila Healthcare Limited, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Hepatitis B Therapeutics - Recent Pipeline Updates, H1 2015
Hepatitis B - Dormant Projects, H1 2015
Hepatitis B - Dormant Projects (Contd..1), H1 2015
Hepatitis B - Dormant Projects (Contd..2), H1 2015
Hepatitis B - Dormant Projects (Contd..3), H1 2015
Hepatitis B - Dormant Projects (Contd..4), H1 2015
Hepatitis B - Dormant Projects (Contd..5), H1 2015
Hepatitis B - Dormant Projects (Contd..6), H1 2015
Hepatitis B - Dormant Projects (Contd..7), H1 2015
Hepatitis B - Dormant Projects (Contd..8), H1 2015
Hepatitis B - Discontinued Products, H1 2015
List of Figures
Number of Products under Development for Hepatitis B, H1 2015
Number of Products under Development for Hepatitis B - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report